UK markets closed

Design Therapeutics, Inc. (DSGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7000-0.0400 (-1.07%)
At close: 04:00PM EDT
3.6000 -0.10 (-2.70%)
After hours: 07:21PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
41,695
57,063
48,613
24,778
6,060
Selling general and administrative
17,633
21,127
18,980
11,053
2,496
Total operating expenses
59,328
78,190
67,593
35,831
8,330
Operating income or loss
-59,328
-78,190
-67,593
-35,831
-8,330
Total other income/expenses net
2,295
11,328
4,285
298
50
Income before tax
-57,033
-66,862
-63,308
-35,533
-8,280
Income from continuing operations
-57,033
-66,862
-63,308
-35,533
-8,280
Net income
-57,033
-66,862
-63,308
-35,533
-8,280
Net income available to common shareholders
-57,033
-66,862
-63,308
-35,533
-8,280
Basic EPS
-1.29
-
-1.14
-0.77
-0.15
Diluted EPS
-1.29
-
-1.14
-0.77
-0.15
Basic average shares
55,928
-
55,708
45,936
53,817
Diluted average shares
55,928
-
55,708
45,936
53,817